|
Market Closed -
Australian S.E.
20:49:24 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.0150 AUD | +66.67% |
|
+66.67% | -37.50% |
| 12:56am | Nexalis Therapeutics Appoints Non-Executive Chairman | MT |
| 08-31 | Nexalis Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.8M 2.64M 2.34M 2.19M 1.99M 3.76M 254M 26.47M 10.26M 130M 9.9M 9.69M 416M | P/E 2024 |
-6.17x | P/E 2025 | -3.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4.1M 2.85M 2.53M 2.36M 2.15M 4.06M 274M 28.6M 11.08M 140M 10.7M 10.47M 449M | EV / Sales 2024 |
18.2x | EV / Sales 2025 | 6.13x |
| Free-Float |
29.26% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +66.67% | ||
| 1 week | +66.67% | ||
| 1 month | +66.67% | ||
| 3 months | +15.38% | ||
| 6 months | -11.76% | ||
| Current year | -37.50% |
| 1 month | 0.01 |  | 0.02 |
| Current year | 0.01 | | 0.03 |
| 1 year | 0.01 | | 0.04 |
| 3 years | 0.01 | | 0.05 |
| 5 years | 0.01 | | 0.13 |
| 10 years | 0.01 | | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darryl Davies
CEO | Chief Executive Officer | - | 2022-09-26 |
Greg Hammond
DFI | Director of Finance/CFO | - | - |
Rob Jenny
CTO | Chief Tech/Sci/R&D Officer | - | 2022-09-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Darryl Davies
BRD | Director/Board Member | - | 2026-06-24 |
Sean Williams
CHM | Chairman | - | 2021-07-26 |
James Barrie
BRD | Director/Board Member | - | 2026-05-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +66.67% | +66.67% | -48.27% | -65.12% | 2.63M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 59.26B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.14B | |
| -0.78% | -4.35% | +26.55% | +33.38% | 42.91B | |
| -0.03% | +0.35% | +350.07% | +685.94% | 44.13B | |
| -1.62% | -2.29% | +2.15% | +97.52% | 40.79B | |
| -0.54% | +2.93% | +9.50% | +50.41% | 30.77B | |
| -2.68% | +5.11% | +33.11% | +19.50% | 29.31B | |
| +1.11% | -7.13% | -28.38% | +331.34% | 23.71B | |
| Average | +6.42% | +6.09% | +42.03% | +135.63% | 39.24B | |
| Weighted average by Cap. | +0.01% | -0.40% | +57.18% | +149.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 402K 279K 248K 232K 211K 398K 26.85M 2.8M 1.09M 13.72M 1.05M 1.03M 44.05M | 986K 686K 609K 569K 518K 977K 65.91M 6.88M 2.67M 33.69M 2.57M 2.52M 108M |
| Net income | -1.21M -841K -747K -697K -635K -1.2M -80.8M -8.44M -3.27M -41.31M -3.16M -3.09M -133M | -1.62M -1.13M -1M -933K -850K -1.6M -108M -11.29M -4.38M -55.29M -4.22M -4.13M -177M |
| Net Debt | -161K -112K -99.33K -92.71K -84.5K -159K -10.75M -1.12M -435K -5.49M -420K -411K -17.63M | 304K 212K 188K 175K 160K 302K 20.34M 2.12M 823K 10.4M 794K 777K 33.37M |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- NX1 Stock
Select your edition
All financial news and data tailored to specific country editions
